Targets › HTR1F
1 program from 1 company in 1 trial: 1 Phase 1; Neurology; next expected readout Dec 2026.
G protein-coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various alkaloids and psychoactive substances. (UniProt, P30939)
Open in Phaseline: the race on HTR1F, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Technophage | Eletriptan Hydrobromide Serotonin 1f (5-HT1f) receptor agonist; Serotonin 1b (5-HT1b) receptor agonist; Serotonin 1d (5-HT1d) receptor agonist | HTR1F, HTR1B, HTR1D | Phase 1 | Acute Spinal Cord Injury (SCI) | Dec 2026 |
Acute Spinal Cord Injury (SCI) (1)
small molecule (1)
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.